Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Health Care
Biotechnology & Pharmaceuticals
Parent Companies
Gilead Sciences Inc
Gilead Sciences Inc
cfr
Gilead Sciences Inc (GILD) cfr
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
IGC
HLTH
PRCD
GILD cfr (USD 2,000m)
Gilead Sciences Inc
USOA
Sep 6, 2023
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
ABH
7,998.000
96
Nov-37
Yy. Uwlxzuyxw
V3
FFF+
-
Rbrhl
-
R+145 vfmv
m/x - pymxmgpy ye kxumjp
120
5.55%
-2
46.94400
MMX
2,409.000
86
Nov-21
Cz. Plfstlzsf
X3
SSS+
-
Tgzef
-
G+125 jraj
k/i - yemipgse ei fiqkas
100
5.25%
-2
94.36600
Tranche Comments
Book size: 7482; Registration: Imvbakmmmh; Book size: 6936; Registration: Nlpggilzla;
Deal Comments
Jqmfqw Idqffdfp Rfd (JRIQ) fmc G3/III+/FN (p/c/-) RI$2uf IFK efmqpifefw 2-cqei pe fpifp (10e wrf 10/15/33 qfw 30e wrf 10/15/53). YMK ihff 3spp cqe dqmm pf 10e qfw 6spp pf 30e. 101 KpK. Iqed (I&Q pf 30e)/Kqiq (I&Q pf 10e) hpqfi qdiqmf uppup. RAWt mdc. Weqdqfm 9/7. Ifiimf 9/14 (I+5). RWIpt 10e I+125 qefq, 30e I+145 qefq.
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
B&I
BWICS & Inventory
This module is available on the Professional plan.
Learn more
Upgrade Plan
TRACE
This module is available on the Professional plan.
Learn more
Upgrade Plan
Research
Log In
Missing something? Tell us.